Half Year 2025 Sigma Healthcare Ltd Earnings Call Transcript
Key Points
- Sigma Healthcare Ltd (SIGGF) reported a 17% increase in normalized revenue for the half-year, driven by the successful onboarding of the new Chemist Warehouse supply contract.
- Normalized EBIT rose by 20% to $18 million, and normalized NPAT surged by over 300% to $13.7 million.
- The company has retained 35% available wholesale capacity to support future growth without major capital expenditure.
- Sigma Healthcare Ltd (SIGGF) maintained high levels of customer service, with on-time delivery metrics above 99% and stock availability improving to around 95%.
- The company has been included in the ASX200 Index, reflecting its positive growth trajectory.
- Operating cash flow was negative $107 million for the six months, primarily due to significant inventory build to support the Chemist Warehouse contract.
- Gross margin percentage slightly decreased from 6.6% to 6.5%, driven by a higher proportion of low-margin PBS medicines sold.
- The company incurred $11.2 million in one-off costs related to the Chemist Warehouse merger proposal and new supply onboarding.
- Sales and marketing costs increased by $3.6 million, partly due to nonrecurring benefits in the prior period and increased paper costs.
- The company faces ongoing pressure on margins due to government efforts to reduce the price of medicines, impacting the fees earned by wholesalers.
Good day and thank you for standing by, and welcome to Sigma Healthcare's half year results briefing. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Managing Director and CEO, Vikesh Ramsunder, Please go ahead.
Good morning. I'm Vikesh Ramsunder, the Chief Executive of Sigma Healthcare, and welcome to our results presentation for the six months ending July 2024.
Before I begin, I wish to acknowledge the Warrenjury people of the Kulin Nation and recognize them as the traditional custodians of the land on which we meet today. I pay my respects to their elders, past, present and emerging. I am joined here today by Mark Conway, our CFO; and Gary Woodford, our Head of Corporate Affairs.
In line with Sigma's ongoing disclosure obligations, we are also joined today by Mark Davis, the CFO of the Chemist Warehouse Group, who will be providing an update on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
